Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor

WARNING: G‐401 and SK‐NEP‐1 cell lines are not Wilms tumor cell lines

(2019) Kathy Pritchard‐Jones et al.   PEDIATRIC BLOOD & CANCER

Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)

(2019) Huaiyu Mi et al.   Nature Protocols

H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo

(2019) André B. Silveira et al.   ACTA NEUROPATHOLOGICA

Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer

(2018) Jenny Karlsson et al.   NATURE GENETICS

Geometry of Gene Expression Space of Wilms' Tumors From Human Patients

(2018) Ariel Trink et al.   NEOPLASIA

Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours

(2018) Xiaotu Ma et al.   NATURE

Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children’s Oncology Group Study

(2017) Emilia Modolo Pinto et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of collagen architecture with glioblastoma patient survival

(2017) Kelli B. Pointer et al.   JOURNAL OF NEUROSURGERY

Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine

(2017) Ela Markovsky et al.   MOLECULAR CANCER THERAPEUTICS

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor

(2017) Samantha Gadd et al.   NATURE GENETICS

Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

(2016) Ariadne H.A.G. Ooms et al.   CLINICAL CANCER RESEARCH

Wilms tumor: “State-of-the-art” update, 2016

(2016) Sabine Irtan et al.   Seminars in Pediatric Surgery

Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences

(2016) Sebastian Moran et al.   Epigenomics

Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences

(2016) Filippo Spreafico et al.   Oncotarget

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications

(2016) George D. Cresswell et al.   EBioMedicine

Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors

(2015) Amy L. Walz et al.   CANCER CELL

Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors

(2015) Jenny Wegert et al.   CANCER CELL

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration

(2015) Jeffrey S. Dome et al.   JOURNAL OF CLINICAL ONCOLOGY

A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone

(2014) Parisa Hesami et al.   CLINICAL & EXPERIMENTAL METASTASIS

A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone

(2014) L. Thibaudeau et al.   Disease Models & Mechanisms

Fate of induced pluripotent stem cells following transplantation to murine seminiferous tubules

(2014) J. Durruthy Durruthy et al.   HUMAN MOLECULAR GENETICS

Orthotopic Wilms tumor xenografts derived from cell lines reflect limited aspects of tumor morphology and clinical characteristics

(2014) Linda Holmquist Mengelbier et al.   PEDIATRIC BLOOD & CANCER

TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia

(2014) Mariana Maschietto et al.   PLoS One

Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk

(2014) Rachel Shukrun et al.   Stem Cell Reports

The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets

(2012) Naomi Pode-Shakked et al.   EMBO Molecular Medicine

A novel retinoblastoma therapy from genomic and epigenetic analyses

(2012) Jinghui Zhang et al.   NATURE

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

(2010) Qianghua Hu et al.   JOURNAL OF CLINICAL INVESTIGATION

Molecular Characterization of the Pediatric Preclinical Testing Panel

(2008) G. Neale et al.   CLINICAL CANCER RESEARCH

Wilms tumor genetics: Mutations inWT1,WTX, andCTNNB1 account for only about one-third of tumors

(2008) E. Cristy Ruteshouser et al.   GENES CHROMOSOMES & CANCER

Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population

(2008) Naomi Pode-Shakked et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Accumulation of Malignant Renal Stem Cells Is Associated with Epigenetic Changes in Normal Renal Progenitor Genes

(2008) Sally Metsuyanim et al.   STEM CELLS

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

(2007) Marcio Malogolowkin et al.   PEDIATRIC BLOOD & CANCER

SK-NEP-1 and Rh1 are Ewing family tumor lines

(2006) Malcolm A. Smith et al.   PEDIATRIC BLOOD & CANCER